Literature DB >> 22187328

Heparan sulfate expression is affected by inflammatory stimuli in primary human endothelial cells.

Trine M Reine1, Marion Kusche-Gullberg, Almir Feta, Trond Jenssen, Svein O Kolset.   

Abstract

In diabetes the endothelium is either chronically or transiently exposed to hyperglycemic conditions. In addition, endothelial dysfunction in diabetes is related to changes in the inflammatory response and the turnover of extracellular matrix. This study was undertaken to study the effects of inflammatory stimuli on one particular matrix component, the heparan sulfate (HS) proteoglycans (PGs) synthesized by primary human umbilical cord vein endothelial cells (HUVEC). Such cells were cultured in vitro in 5 mM and 25 mM glucose. The latter concentration was used to mimic hyperglycemic conditions in short-term experiments. HUVEC were also cultured in the presence of the inflammatory agents tumor necrosis factor α (TNF-α), interleukin 1α (IL-1α), interleukin 1β (IL-1β) and transforming growth factor β (TGF-β). The cells were labeled with (35)S-sulfate and (35)S-PGs were recovered for further analyses. The major part of the (35)S-PGs was secreted to the medium, irrespective of type of stimuli. Secreted (35)S-PGs were therefore isolated and subjected to further analyses. TNF-α and IL-1α slightly increased the release of (35)S-PGs to the culture medium, whereas IL-1β treatment gave a significant increase. The different treatments neither changed the ratio of (35)S-HS and (35)S-chondroitin sulfate (CS) nor the macromolecular properties of the (35)S-PGs. However, the (35)S-HS chains were slightly increased in size after TNF-α treatment, and slightly decreased after TGF-β treatment, but not affected by the other treatments. Compositional analysis of labeled disaccharides showed changes in the amount of 6-O-sulfated glucosamine residues after treatment with TNF-α, IL-1α and IL-1β. Western immunoblotting showed that major HSPGs recovered from these cells were collagen XVIII, perlecan and agrin, and that secretion of these distinct PGs was increased after IL-1β stimulation. Hence, short term inflammatory stimuli increased the release of HSPGs in HUVEC and affected both the size and sulfation pattern of HS, depending on type of stimuli.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22187328     DOI: 10.1007/s10719-011-9365-y

Source DB:  PubMed          Journal:  Glycoconj J        ISSN: 0282-0080            Impact factor:   2.916


  33 in total

1.  The AGE product N epsilon-(carboxymethyl)lysine serum albumin is a modulator of proteoglycan expression in polarized cultured kidney epithelial cells.

Authors:  J Borrebaek; K Prydz; K Fjeldstad; T T Vuong; T J Berg; C Holkov; S O Kolset
Journal:  Diabetologia       Date:  2001-04       Impact factor: 10.122

2.  Serglycin is a major proteoglycan in polarized human endothelial cells and is implicated in the secretion of the chemokine GROalpha/CXCL1.

Authors:  Astri J Meen; Inger Øynebråten; Trine M Reine; Annette Duelli; Katja Svennevig; Gunnar Pejler; Trond Jenssen; Svein O Kolset
Journal:  J Biol Chem       Date:  2010-11-12       Impact factor: 5.157

3.  Endothelial heparan sulfate controls chemokine presentation in recruitment of lymphocytes and dendritic cells to lymph nodes.

Authors:  Xingfeng Bao; E Ashley Moseman; Hideo Saito; Bronislawa Petryniak; Bronislawa Petryanik; Aude Thiriot; Shingo Hatakeyama; Yuki Ito; Hiroto Kawashima; Yu Yamaguchi; John B Lowe; Ulrich H von Andrian; Minoru Fukuda
Journal:  Immunity       Date:  2010-11-24       Impact factor: 31.745

4.  WT1-dependent sulfatase expression maintains the normal glomerular filtration barrier.

Authors:  Valérie A Schumacher; Ursula Schlötzer-Schrehardt; S Ananth Karumanchi; Xiaofeng Shi; Joseph Zaia; Stefanie Jeruschke; Dongsheng Zhang; Hermann Pavenstädt; Hermann Pavenstaedt; Astrid Drenckhan; Kerstin Amann; Carrie Ng; Sunny Hartwig; Kar-Hui Ng; Jacqueline Ho; Jordan A Kreidberg; Mary Taglienti; Brigitte Royer-Pokora; Xingbin Ai
Journal:  J Am Soc Nephrol       Date:  2011-06-30       Impact factor: 10.121

Review 5.  Advanced glycation end products: sparking the development of diabetic vascular injury.

Authors:  Alison Goldin; Joshua A Beckman; Ann Marie Schmidt; Mark A Creager
Journal:  Circulation       Date:  2006-08-08       Impact factor: 29.690

6.  VEGF165-binding sites within heparan sulfate encompass two highly sulfated domains and can be liberated by K5 lyase.

Authors:  Christopher J Robinson; Barbara Mulloy; John T Gallagher; Sally E Stringer
Journal:  J Biol Chem       Date:  2005-10-28       Impact factor: 5.157

7.  Domain structure of heparan sulfates from bovine organs.

Authors:  M Maccarana; Y Sakura; A Tawada; K Yoshida; U Lindahl
Journal:  J Biol Chem       Date:  1996-07-26       Impact factor: 5.157

8.  Heparin's anti-inflammatory effects require glucosamine 6-O-sulfation and are mediated by blockade of L- and P-selectins.

Authors:  Lianchun Wang; Jillian R Brown; Ajit Varki; Jeffrey D Esko
Journal:  J Clin Invest       Date:  2002-07       Impact factor: 14.808

9.  Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria.

Authors:  E A Jaffe; R L Nachman; C G Becker; C R Minick
Journal:  J Clin Invest       Date:  1973-11       Impact factor: 14.808

10.  Blood platelets stimulate the expression of chondroitin sulfate proteoglycan in human monocytes.

Authors:  L Uhlin-Hansen; D Langvoll; T Wik; S O Kolset
Journal:  Blood       Date:  1992-08-15       Impact factor: 22.113

View more
  12 in total

Review 1.  Role of the endothelial surface layer in neutrophil recruitment.

Authors:  Alex Marki; Jeffrey D Esko; Axel R Pries; Klaus Ley
Journal:  J Leukoc Biol       Date:  2015-05-15       Impact factor: 4.962

2.  Loss of endothelial sulfatase-1 after experimental sepsis attenuates subsequent pulmonary inflammatory responses.

Authors:  Kaori Oshima; Xiaorui Han; Yilan Ouyang; Rana El Masri; Yimu Yang; Sarah M Haeger; Sarah A McMurtry; Trevor C Lane; Pavel Davizon-Castillo; Fuming Zhang; Xinping Yue; Romain R Vivès; Robert J Linhardt; Eric P Schmidt
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2019-08-28       Impact factor: 5.464

Review 3.  Proteoglycans in liver cancer.

Authors:  Kornélia Baghy; Péter Tátrai; Eszter Regős; Ilona Kovalszky
Journal:  World J Gastroenterol       Date:  2016-01-07       Impact factor: 5.742

Review 4.  The "in and out" of glucosamine 6-O-sulfation: the 6th sense of heparan sulfate.

Authors:  Rana El Masri; Amal Seffouh; Hugues Lortat-Jacob; Romain R Vivès
Journal:  Glycoconj J       Date:  2016-11-03       Impact factor: 2.916

5.  Extracellular sulfatase-2 is overexpressed in rheumatoid arthritis and mediates the TNF-α-induced inflammatory activation of synovial fibroblasts.

Authors:  Ruby J Siegel; Anil K Singh; Paul M Panipinto; Farheen S Shaikh; Judy Vinh; Sang U Han; H Mark Kenney; Edward M Schwarz; Cynthia S Crowson; Sadik A Khuder; Basil S Khuder; David A Fox; Salahuddin Ahmed
Journal:  Cell Mol Immunol       Date:  2022-09-07       Impact factor: 22.096

Review 6.  Effect of Polarization and Chronic Inflammation on Macrophage Expression of Heparan Sulfate Proteoglycans and Biosynthesis Enzymes.

Authors:  Maarten Swart; Linda Troeberg
Journal:  J Histochem Cytochem       Date:  2018-09-11       Impact factor: 2.479

Review 7.  Glycoconjugates and related molecules in human vascular endothelial cells.

Authors:  Norihiko Sasaki; Masashi Toyoda
Journal:  Int J Vasc Med       Date:  2013-09-19

8.  Serglycin in Quiescent and Proliferating Primary Endothelial Cells.

Authors:  Trine M Reine; Tram T Vuong; Arkady Rutkovskiy; Astri J Meen; Jarle Vaage; Trond G Jenssen; Svein O Kolset
Journal:  PLoS One       Date:  2015-12-22       Impact factor: 3.240

9.  HS and Inflammation: A Potential Playground for the Sulfs?

Authors:  Rana El Masri; Yoann Crétinon; Evelyne Gout; Romain R Vivès
Journal:  Front Immunol       Date:  2020-04-03       Impact factor: 7.561

Review 10.  Review of Alterations in Perlecan-Associated Vascular Risk Factors in Dementia.

Authors:  Amanda L Trout; Ibolya Rutkai; Ifechukwude J Biose; Gregory J Bix
Journal:  Int J Mol Sci       Date:  2020-01-20       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.